Spears Abacus Advisors LLC Bio N Tech Se Transaction History
Spears Abacus Advisors LLC
- $4.12 Billion
- Q1 2025
A detailed history of Spears Abacus Advisors LLC transactions in Bio N Tech Se stock. As of the latest transaction made, Spears Abacus Advisors LLC holds 4,000 shares of BNTX stock, worth $425,320. This represents 0.01% of its overall portfolio holdings.
Number of Shares
4,000
Previous 4,000
-0.0%
Holding current value
$425,320
Previous $455,000
20.0%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding BNTX
# of Institutions
340Shares Held
40MCall Options Held
1.43MPut Options Held
1.54M-
Baillie Gifford & CO8.16MShares$868 Million0.67% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.26MShares$453 Million1.71% of portfolio
-
Primecap Management CO Pasadena, CA4.05MShares$430 Million0.31% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$202 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$192 Million0.84% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $25.8B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...